Locke Lord Adds Providence Partner to Firm’s Executive Committee

December 9, 2015 – Locke Lord LLP has elected Providence Partner Christopher D. Graham to serve on the Firm’s Executive Committee.

The new Executive Committee Member brings a high level of commitment and dedication to the Firm’s leadership team. Graham serves as the Providence Office Managing Partner and is Co-Chair of Locke Lord’s Corporate and Transactional Department.  

“Chris is a highly-regarded lawyer who will provide the Committee important perspectives on key issues as Locke Lord continues to expand its breadth and depth,” said Locke Lord Chair Jerry K. Clements. “The Providence office is a very important part of the Locke Lord footprint, and we value the perspectives Chris will offer the leadership team as we constantly improve our strategy for partnering with clients.”

Graham’s practice focuses on matters involving private equity. He has led teams of lawyers in various types of corporate transactions, both domestic and cross-border. His clients include private equity funds, Fortune 500 companies, international conglomerates, privately-held manufacturing companies and numerous technology and life science start-ups.

Clements serves as head of the Firm’s Executive Committee, with Alan Levin, Daniel Schlessinger and Bill Swanstrom acting as Vice Chairs. Also remaining on Locke Lord’s Executive Committee are Nick DiGiovanni, Michael Gaertner, Janis Loegering, Walter St. Onge, Heather Stone, David Taylor, George Ticknor, Jonathan Young and Thomas Yoxall.

###

About Locke Lord LLP
Locke Lord is a full-service, international law Firm of 23 offices designed to meet clients’ needs around the world. With a combined history of more than 125 years and a greatly enhanced domestic and global footprint, Locke Lord is a worldwide leader in the middle market sector. Locke Lord advises clients across a broad spectrum of industries including energy, insurance and reinsurance, private equity, telecommunications, technology, real estate, financial services and health care and life sciences, while providing a wealth of experience through its complex litigation, regulatory, intellectual property and fund formation teams.